Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,934 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Environmental Public Health Tracking, an untapped resource for occupational health.
Namulanda G, Monti M, Werner A, Nogueira I, Solomon G, English P, Karlsson N, Cosser A, Bush K, Mitchell C. Namulanda G, et al. Among authors: mitchell c. J Occup Environ Hyg. 2022 Oct-Nov;19(10-11):591-595. doi: 10.1080/15459624.2022.2123494. Epub 2022 Sep 28. J Occup Environ Hyg. 2022. PMID: 36099082 No abstract available.
Chemical hazards in radiology.
Byrns GE, Palatianos KH, Shands LA, Fennelley KP, McCammon CS, Boudreau AY, Breysse PN, Mitchell CS. Byrns GE, et al. Among authors: mitchell cs. Appl Occup Environ Hyg. 2000 Feb;15(2):203-8. doi: 10.1080/104732200301700. Appl Occup Environ Hyg. 2000. PMID: 10675978
Erratum. Identifying Preferred Features of Weight Loss Programs for Adults With or at Risk of Type 2 Diabetes: A Discrete Choice Experiment With 3,960 Adults in the U.K.. Diabetes Care 2024;47:739-746.
Buckell J, Mitchell CA, Fryer K, Newbert C, Brennan A, Joyce J, Jebb SA, Aveyard P, Guess N, Morris E. Buckell J, et al. Among authors: mitchell ca. Diabetes Care. 2024 May 10:dc24er07b. doi: 10.2337/dc24-er07b. Online ahead of print. Diabetes Care. 2024. PMID: 38728103
Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trial.
Murphy AD, Porter C, White A, Irving A, Adams R, Ray R, Casbard A, Mahmood RD, Karanth S, Zhou C, Pugh J, Wheeler C, Roberts V, Arnetoli G, Salih Z, Hasan J, Mitchell C, Morgan RD, Clamp AR, Jayson GC. Murphy AD, et al. Among authors: mitchell c. Int J Gynecol Cancer. 2024 May 9:ijgc-2024-005455. doi: 10.1136/ijgc-2024-005455. Online ahead of print. Int J Gynecol Cancer. 2024. PMID: 38724236
3,934 results